The knockout of ME1, a major cytoplasmic NADP+-reducing enzyme in WAT [18] and a contributor to the reduction of cytoplasmic NADP+ to NADPH in the liver [19], led to decreased liver steatosis, fat mass, and obesity, and improvement in glucose tolerance [56]. The gene discussed is ME1; the disease is obesity disorder.